Clinical trial
替雷利珠单抗联合含铂双药新辅助治疗用于提高可切除局部晚期口腔鳞癌下颌骨保留的前瞻性、单臂Ⅱ期临床试验
NCT06130007 is registered in ClinicalTrials.gov with Xuekui Liu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 替雷利珠单抗联合含铂双药新辅助治疗用于提高可切除局部晚期口腔鳞癌下颌骨保留的前瞻性、单臂Ⅱ期临床试验
- Lead sponsor
- Xuekui Liu
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 25, 2023
- Completion date
- October 25, 2024
- Enrollment
- 48 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
oral squamous cell carcinoma